N,N-Dipropyltryptamine (DPT) is the tryptamine that makes DMT look gentle. Known in underground psychedelic circles as "The Light" -- a name inherited from the Temple of the True Inner Light, a New York City religious organization that uses it as its primary sacrament -- DPT produces experiences that seasoned psychonauts consistently rank among the most intense, confrontational, and spiritually charged in the entire tryptamine family. Where DMT is often described as warm, organic, and maternal, DPT earns adjectives like "alien," "dark," "annihilating," and "holy." It is not the tryptamine you recommend to a friend. It is the one you warn them about.
Structurally, DPT is DMT with both methyl groups replaced by propyl chains. This seemingly modest elongation transforms the pharmacology in ways that matter enormously in practice: DPT is orally active without an MAOI (unlike DMT, which is destroyed by gut MAO-A), it has significant affinity for sigma-1 receptors (which may explain its dissociative, reality-rending character), and its duration stretches to 2-4 hours orally or 20-60 minutes when smoked -- long enough that the experience cannot be dismissed as a flash but short enough that it demands surrender rather than navigation. Common oral doses range from 100-250 mg, reflecting substantially lower potency per milligram than DMT but not lesser intensity. The intensity is, by most accounts, greater.
DPT was briefly studied clinically in the 1970s at the Maryland Psychiatric Research Center, where researchers including collaborators of Stanislav Grof explored its use in psychedelic psychotherapy for alcoholism and terminal illness anxiety. The clinical literature from that era describes DPT as reliably producing powerful mystical experiences -- the kind of ontological earthquakes that researchers believed could catalyze lasting psychological change. That research ended with the same wave of prohibition that shut down LSD and psilocybin work, and DPT has not returned to the clinical setting since.
What the clinical researchers documented, and what Reddit trip reports echo decades later, is that DPT does not offer the warm cosmic hug that characterizes psilocybin or the electric revelation of LSD. It offers obliteration. Users describe being taken apart at a molecular level, encountering vast intelligences in spaces that feel more like cathedrals of darkness than the jeweled palaces of DMT, and returning with the shaken conviction that they have touched something real and indifferent to their comfort. This is not a compound that cares whether you enjoy it.
Safety at a Glance
High Risk- This Is Not a Beginner Compound
- Route of Administration Matters Enormously
- Toxicity: Acute Physical Toxicity No modern formal toxicological data exists for DPT in humans. The 1970s clinical studies at t...
- Overdose risk: Can You Fatally Overdose on DPT? Fatal overdose from DPT's pharmacological action alone is extrem...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Dosage
insufflated
oral
smoked
Duration
insufflated
Total: 3 hrs – 5 hrsoral
Total: 2 hrs – 4 hrssmoked
Total: 30 min – 1.5 hrsHow It Feels
The onset of DPT does not creep. It announces itself. Thirty to sixty minutes after swallowing a capsule of the freebase or fumarate, a dark, heavy pressure begins building in the chest and abdomen -- not nausea exactly, though nausea is common, but a gravitational pull inward, as if consciousness itself is being drawn toward some dense center. The room darkens. Not literally, but perceptually -- colors mute and deepen, shadows thicken, and the ambient light seems to lose its warmth. There is a distinct bodily heaviness, a sense that you are being pressed down into whatever surface you are lying on. Users who have experienced both consistently note that where DMT's onset feels like being launched upward, DPT's feels like being pulled under.
Over the next thirty to sixty minutes, the visual field transforms into something genuinely unlike any other tryptamine. The geometry is dark, monumental, and architectural: vast crystalline structures extending into impossible depths, gothic arches that span what feels like miles, and patterns that are less decorative than structural -- as if you are seeing the scaffolding of reality rather than its surface. The color palette is distinctive and consistent across reports: deep reds so dark they border on black, golds shot through with shadow, purples approaching ultraviolet, and a pervasive darkness that does not feel threatening so much as fundamental. Closed-eye visuals are not merely vivid -- they are encompassing, three-dimensional spaces you inhabit rather than images you observe. Users describe cathedrals, abysses, vast mechanical systems, and architectures that feel ancient and purposeful.
The peak, arriving at roughly ninety minutes to two hours orally and sustained for two to four hours, is where DPT earns every word of its reputation. Ego dissolution arrives not as a gradual melting but as a dismantling -- rapid, thorough, and often terrifying. The sense of being a person with a name and a history is stripped away in layers, and what remains is raw awareness in a space that does not care about you. Many users report encountering what they call "The Light" -- a blinding, all-encompassing radiance that feels simultaneously annihilating and unconditionally loving. Others describe the opposite: vast, dark voids populated by intelligences that communicate through symbol, geometry, and an emotional pressure that bypasses language entirely. Both descriptions frequently appear in the same trip report. Terror and ecstasy collapse into each other. Grief and revelation arrive simultaneously. The body is functionally forgotten.
The return from DPT is not a gentle landing. Reintegration happens in lurching stages over three to five hours as ordinary selfhood reassembles. There are waves of emotional release -- crying, shaking, laughter that feels more like relief than joy. Physical exhaustion is substantial, the kind of tiredness that goes deeper than muscles. The afterglow is complex and can persist for days: a mixture of awe, fragility, and a quiet knowing that resists every attempt to put it into words. Many users do not describe DPT as a drug experience. They describe it as something that happened to them.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(18)
- Abnormal heartbeat— Abnormal heartbeat (arrhythmia) is any deviation from the heart's normal rhythm — including beats th...
- Changes in felt bodily form— Changes in felt bodily form is the experience of one's body feeling as though it has altered its phy...
- Changes in felt gravity— A distortion of one's proprioceptive sense of gravity in which the perceived direction of gravitatio...
- Dehydration— A state of insufficient bodily hydration manifesting as persistent thirst, dry mouth, and physical d...
- Excessive yawning— Involuntary, repeated yawning that occurs far more frequently than normal and often without the usua...
- Headache— A painful sensation of pressure, throbbing, or aching in the head that can range from a dull backgro...
- Increased blood pressure— Increased blood pressure (hypertension) is an elevation of arterial pressure above the normal 120/80...
- Increased libido— A marked enhancement of sexual desire, arousal, and sensitivity to erotic stimuli that can range fro...
- Laughter fits— Spontaneous, uncontrollable, and often prolonged episodes of intense laughter that erupt without any...
- Motor control loss— A distinct decrease in the ability to control one's physical body with precision, balance, and coord...
- Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
- Physical autonomy— Physical autonomy is the experience of one's body performing actions — from simple tasks like walkin...
- Physical euphoria— An intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity...
- Pupil dilation— A visible enlargement of the pupil diameter (mydriasis) that can range from subtle widening to drama...
- Seizure— Uncontrolled brain electrical activity causing convulsions and loss of consciousness -- a life-threa...
- Serotonin syndrome— Serotonin syndrome is a potentially fatal medical emergency caused by excessive serotonergic activit...
- Spatial disorientation— Spatial disorientation is the inability to accurately perceive one's position or orientation within ...
- Tremors— Involuntary rhythmic shaking of the hands, limbs, or body, ranging from fine tremor to gross shaking...
Cognitive & Perceptual Effects
Visual(21)
- After images— A visual phenomenon in which a faint, ghostly imprint of a previously viewed image persists in the v...
- Colour enhancement— An intensification of the brightness, vividness, and saturation of colors in the external environmen...
- Colour replacement— A visual phenomenon in which the colors of objects or the entire visual field are statically replace...
- Colour shifting— The visual experience of colors on objects and surfaces cycling through continuous, fluid transforma...
- Drifting— The visual experience of perceiving stationary objects, textures, and surfaces as appearing to flow,...
- Environmental patterning— A visual effect in which existing textures and surfaces — carpets, clouds, foliage, walls — spontane...
- External hallucination— A visual hallucination that manifests within the external environment as though it were physically r...
- Geometry— The experience of perceiving complex, ever-shifting geometric patterns superimposed over the visual ...
- Internal hallucination— Vivid, detailed visual experiences perceived within an imagined mental landscape that can only be se...
- Magnification— A visual distortion in which objects appear larger or closer than they actually are, as though one's...
- Pattern recognition enhancement— An increased ability and tendency to perceive meaningful patterns, faces, and images within ambiguou...
- Perspective hallucination— A hallucinatory phenomenon in which the observer's visual perspective shifts from the normal first-p...
- Recursion— The visual field begins to repeat and nest within itself in a self-similar, fractal-like manner, as ...
- Scenery slicing— The visual field fractures into distinct, cleanly cut sections that slowly drift apart from their or...
- Settings, sceneries, and landscapes— The perceived environment in which hallucinatory experiences take place, ranging from recognizable l...
- Symmetrical texture repetition— Textures appear to mirror and tessellate across surfaces in intricate, self-similar symmetrical patt...
- Tracers— Moving objects leave visible trails of varying length and opacity behind them, similar to long-expos...
- Transformations— Objects and scenery undergo perceived visual metamorphosis, smoothly shapeshifting into other recogn...
- Visual acuity enhancement— Vision becomes sharper and more defined than normal, as though a slightly blurry lens has been broug...
- Visual exposure to inner mechanics of consciousness— A high-level hallucinatory state in which the observer perceives masses of complex, innately readabl...
- Visual haze— A translucent fog or haze overlays the visual field, softening the environment and reducing clarity....
Cognitive(24)
- Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
- Autonomous voice communication— Autonomous voice communication is the experience of hearing and engaging in conversation with one or...
- Catharsis— A powerful emotional release and cleansing involving the surfacing, processing, and resolution of de...
- Cognitive dysphoria— A cognitive and emotional state of intense dissatisfaction, discomfort, and malaise encompassing fee...
- Cognitive euphoria— A cognitive and emotional state of intense well-being, elation, happiness, and joy that manifests as...
- Conceptual thinking— A shift in the nature of thought from verbal, linear sentence structures to intuitive, non-linguisti...
- Confusion— An impairment of abstract thinking marked by a persistent inability to grasp or comprehend concepts ...
- Deja vu— Intense, often prolonged sensation of having already experienced the current moment, common with psy...
- Feelings of impending doom— Feelings of impending doom is the sudden onset of an overwhelming, visceral certainty that something...
- Immersion enhancement— A heightened capacity to become fully absorbed and engrossed in external media such as music, films,...
- Increased sense of humor— A general amplification of one's sensitivity to finding things humorous and amusing, often causing p...
- Language suppression— A diminished ability to formulate, comprehend, or articulate language, ranging from difficulty findi...
- Memory suppression— A dose-dependent inhibition of one's ability to access and utilize short-term and long-term memory, ...
- Multiple thought streams— The experience of having more than one internal narrative or stream of consciousness simultaneously ...
- Novelty enhancement— A feeling of increased fascination, awe, and childlike wonder attributed to everyday concepts, objec...
- Paranoia— Irrational suspicion and belief that others are watching, plotting against, or intending harm toward...
- Personal bias suppression— A decrease in the personal, cultural, and cognitive biases through which one normally filters their ...
- Personal meaning enhancement— Personal meaning enhancement is a state in which everyday events, coincidences, song lyrics, environ...
- Psychosis— Psychosis is a serious psychiatric state involving a fundamental break from consensus reality — char...
- Rejuvenation— A renewed sense of physical vitality, mental freshness, and emotional restoration that can emerge du...
- Thought disorganization— Thought disorganization is a cognitive impairment in which the normal capacity for structured, seque...
- Thought loops— Becoming trapped in a repeating cycle of thoughts, actions, and emotions that loops every few second...
- Time distortion— Subjective perception of time becomes dramatically altered — minutes may feel like hours, or hours p...
- Wakefulness— An increased ability to stay awake and alert without the desire to sleep. Distinct from stimulation ...
Multi-sensory(3)
- Machinescapes— Machinescapes are complex multisensory hallucinations involving the perception of enormous mechanica...
- Scenarios and plots— Scenarios and plots are the narrative structures that emerge within hallucinatory states — coherent ...
- Synaesthesia— Stimulation of one sense triggers involuntary experiences in another — seeing sounds as colors, tast...
Transpersonal(7)
- Death simulation— Profound subjective experience of dying, including life review, acceptance, and dissolution, distinc...
- Ego death— A profound dissolution of the sense of self in which personal identity, memories, and the boundary b...
- Existential self-realization— A sudden, visceral realization of the profound significance and improbability of one's own existence...
- Perception of eternalism— The experience that all moments across the timeline of existence are equally real and simultaneously...
- Perception of predeterminism— Perception of predeterminism is the powerful subjective experience of feeling — not merely thinking,...
- Spirituality enhancement— A profound intensification of spiritual feelings, mystical awareness, and a sense of sacred connecti...
- Unity and interconnectedness— A profound sense that identity extends beyond the self to encompass other people, nature, or all of ...
Pharmacology
Mechanism of Action
DPT is a potent partial agonist at serotonin 5-HT2A receptors, the central mechanism shared with all classical tryptamine psychedelics. Animal studies have confirmed that selective 5-HT2A antagonists completely block DPT's behavioral effects, leaving no ambiguity about the primary pharmacological target. However, stopping at 5-HT2A misses what makes DPT pharmacologically distinctive.
5-HT1A receptor involvement is significant. Animal models show that 5-HT1A antagonists modulate DPT's behavioral signature in ways not seen with simpler tryptamines, suggesting a more complex serotonergic pharmacology than DMT. The interplay between 5-HT2A activation (psychedelic effects) and 5-HT1A modulation (anxiolytic and emotional coloring) likely contributes to DPT's unique character -- a quality users describe as simultaneously terrifying and serene.
Sigma-1 Receptor Activity
DPT binds to sigma-1 receptors with meaningful affinity, and this may be the pharmacological key to its distinctive darkness. Sigma-1 receptors are intracellular chaperone proteins concentrated in the endoplasmic reticulum that modulate calcium signaling, neuroplasticity, and cellular stress responses. Their activation is associated with altered states of consciousness, dissociative phenomena, and a quality of experience that users consistently describe as "other" -- alien, vast, and impersonal. DMT also binds sigma-1, but DPT's affinity appears more pronounced, potentially explaining why DPT experiences feel less organic and more architecturally strange.
Oral Bioavailability
DPT is orally active without MAOI co-administration -- a critical distinction from DMT. The N-propyl groups reduce MAO-A substrate affinity enough that a meaningful fraction survives first-pass metabolism. However, oral bioavailability is partial, requiring doses of 100-250 mg orally compared to 20-60 mg insufflated. Insufflation and smoking produce faster onset, more intense effects, and shorter duration. Intramuscular injection was the route used in clinical research but is rare outside that context.
Pharmacokinetics
Oral onset: 45-90 minutes. Peak: 2-3 hours. Total duration: 3-6 hours orally. Insufflated onset: 5-15 minutes, with peak at 20-40 minutes and total duration of 1-3 hours. Smoked onset is near-immediate, duration 20-60 minutes. Metabolism proceeds via N-depropylation by CYP450 enzymes and MAO oxidation. No comprehensive human pharmacokinetic study has been published.
Tolerance
Rapid tolerance within 24-48 hours. Full cross-tolerance with DMT, psilocybin, LSD, and other 5-HT2A agonists. Tolerance resets within approximately 7-14 days.
Detection Methods
Urine Detection
DPT is not targeted by standard immunoassay-based urine drug screens. As a tryptamine, it is metabolized through monoamine oxidase pathways and produces hydroxylated and deaminated metabolites that are excreted renally. Specialized LC-MS/MS methods can detect tryptamine metabolites in urine for approximately 24 to 48 hours after ingestion. The short duration of action of most base tryptamines results in a relatively brief detection window compared to longer-acting psychoactive substances.
Blood and Serum Detection
Blood detection windows for DPT are short, typically 4 to 12 hours after oral administration. If smoked or insufflated, peak concentrations occur within minutes and clearance is more rapid. LC-MS/MS is required for reliable blood detection at the low concentrations characteristic of tryptamine compounds. The rapid metabolism by MAO-A significantly limits the time window in which blood sampling can capture meaningful concentrations.
Standard Drug Panel Inclusion
DPT is NOT included on standard 5-panel, 10-panel, or 12-panel drug screens. Tryptamines do not cross-react with immunoassay targets for amphetamines, cannabinoids, cocaine metabolites, opiates, PCP, or any other standard panel analyte. Detection requires specific testing at a reference laboratory capable of novel psychoactive substance analysis. Even extended clinical panels rarely include base tryptamines.
Confirmatory Methods
Confirmatory identification of DPT relies on LC-MS/MS or GC-MS with appropriate reference standards. GC-MS analysis of tryptamines may require derivatization for optimal sensitivity and chromatographic performance. Reference laboratories specializing in novel psychoactive substances provide the most comprehensive detection capabilities. Standard clinical toxicology laboratories generally do not maintain validated methods for base tryptamines.
Reagent Testing (Harm Reduction)
The Ehrlich reagent produces a purple to violet reaction with DPT, confirming the presence of an indole ring system. This is the primary field identification tool and should be used as the first screening test. The Hofmann reagent provides a confirmatory blue to purple reaction. The Marquis reagent typically shows no reaction or a slight brown-yellow discoloration with base tryptamines. A positive Ehrlich result confirms the tryptamine class but does not identify the specific compound. Multiple reagents should be used together for greater confidence in identification.
Interactions
| Substance | Status | Note |
|---|---|---|
| 2-Aminoindane | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2-FA | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2-FEA | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2-FMA | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2,5-DMA | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 1,3-Butanediol | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 1B-LSD | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 1cP-AL-LAD | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 1cP-LSD | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 1cP-MiPLA | Low Risk & Synergy | Cross-tolerance exists; effects compound |
History
Synthesis and Early Pharmacology (1950s-1960s)
DPT was first synthesized in the mid-20th century as part of the systematic exploration of N,N-dialkyl tryptamine pharmacology that had already produced DMT, DET, and other members of the series. Its position between DET (diethyl) and the higher dialkyl analogs was of academic interest. Early pharmacological characterization identified it as psychoactive and, critically, orally active without MAOI co-administration -- a property that distinguished it from DMT and made it more practical for controlled administration.
Clinical Research at the Maryland Psychiatric Research Center (1970s)
DPT's most significant chapter in formal research occurred at the Maryland Psychiatric Research Center during the 1970s, where researchers including colleagues of Stanislav Grof investigated its application in psychedelic-assisted psychotherapy. DPT was administered to patients with alcoholism and anxiety associated with terminal illness. The clinical reports documented that DPT reliably produced powerful mystical and peak experiences -- the kind of ego-dissolving, reality-restructuring events that the psychedelic therapy model held to be catalysts for lasting psychological change. This work was part of the final wave of clinical psychedelic research before the political backlash of the War on Drugs effectively shut down the field by the late 1970s.
Temple of the True Inner Light (1979-Present)
The most remarkable chapter in DPT's cultural history is the Temple of the True Inner Light, a syncretic religious organization founded in 1979 and based in Manhattan's Lower East Side. The Temple regards DPT and other tryptamines as divine sacraments -- not metaphorically, but literally, holding that these molecules are manifestations of God. DPT is the Temple's primary sacrament, and its use within the organization gave the compound its enduring nickname: "The Light." The Temple has operated continuously since its founding, representing one of the very few organized religious communities built around a synthetic tryptamine.
Underground Reputation (1980s-Present)
Following the end of clinical research, DPT circulated primarily in underground psychedelic communities, where it developed a reputation that has only grown more formidable over time. Community documentation on Reddit, Erowid, and harm reduction platforms consistently distinguishes DPT from the more commonly discussed tryptamines, treating its dark, confrontational character not as a liability but as its essential identity. As of 2026, DPT has not returned to clinical research, though the broader psychedelic renaissance has renewed academic interest in the therapeutic potential of mystical experience-producing compounds.
Harm Reduction
This Is Not a Beginner Compound
DPT consistently produces experiences of exceptional psychological intensity. Users with years of psychedelic experience and dozens of sessions under their belt describe DPT as qualitatively more intense and confrontational than anything they have previously encountered. If you have not worked extensively with other psychedelics -- psilocybin, LSD, DMT -- you are not ready for DPT. This is not gatekeeping; it is the unanimous assessment of people who have been there.
Route of Administration Matters Enormously
- Oral is the recommended route for harm reduction. Onset is slower (45-90 minutes), allowing gradual adjustment, and duration is longer (3-6 hours) but more manageable in intensity per minute
- Insufflation produces rapid onset (5-15 minutes), more intense peak effects, and shorter total duration (1-3 hours). The speed of onset makes it significantly harder to manage psychologically
- Smoking/vaporization is near-immediate onset and the most intense route. Duration is 20-60 minutes. Reserved for experienced users only
- Intramuscular injection was used in clinical research but carries additional risks (sterility, accurate dosing) and is not recommended outside clinical supervision
Dosing
- Oral -- Threshold: 50-75 mg | Common: 100-175 mg | Strong: 175-250 mg | Heavy: 250+ mg
- Insufflated -- Threshold: 15-25 mg | Common: 30-75 mg | Strong: 75-100+ mg
- Individual sensitivity varies widely. Start at the low end of the common range for your chosen route
- A milligram-accurate scale is mandatory. DPT's dose-response curve steepens sharply at higher ranges
Preparation Is Everything
- Clear your schedule for 24 hours minimum. DPT aftereffects persist well beyond the acute experience
- Have an experienced, trusted sober sitter present. This is not optional for DPT -- the intensity of ego dissolution and the dark character of the experience can produce states where the user needs external anchoring
- Have a benzodiazepine available (diazepam 10-20 mg or equivalent) as emergency rescue medication
- Set clear intentions, but hold them loosely. DPT tends to pursue its own agenda regardless of yours
- Ensure physical comfort: lying down position, warm blankets, low lighting, minimal external stimulation
Working With the Darkness
DPT's confrontational, dark character is its defining feature, not a side effect. Users who have navigated difficult DPT experiences consistently report that resistance amplifies distress while surrender reduces it. The instruction passed through community wisdom is simple and difficult: let it take you. Fighting the dissolution of self is what converts intensity into suffering. This does not mean every DPT experience will be pleasant -- many are not -- but the difference between a harrowing experience and a traumatizing one often comes down to whether the user can relinquish control.
Toxicity & Safety
Acute Physical Toxicity
No modern formal toxicological data exists for DPT in humans. The 1970s clinical studies at the Maryland Psychiatric Research Center administered DPT to patients under medical supervision without identifying significant physiological toxicity within the therapeutic dose range. Based on class membership (classical tryptamine psychedelic) and the wide therapeutic index characteristic of serotonergic psychedelics, acute physiological toxicity at standard doses is presumed low.
Route-Specific Physical Risks
- Oral -- Nausea is common and can be forceful during onset. The extended duration (3-6 hours) places sustained cardiovascular stress (mild tachycardia, blood pressure elevation) on the body, though this is well-tolerated in healthy individuals
- Insufflation -- Significant nasal irritation and pain. Potential for mucosal damage and septal erosion with repeated use. The rapid onset (5-15 minutes) creates a compressed, more intense cardiovascular response
- Smoking/vaporization -- Respiratory tract irritation. Near-immediate onset eliminates the gradual adjustment period, maximizing psychological risk
- Injection -- Infection risk, vein damage, and dose accuracy concerns. The clinical route; not recommended outside supervised settings
Psychological Risks: The Primary Concern
DPT's psychological risk profile is the most serious consideration, exceeding that of most other classical psychedelics:
- Severe ego dissolution -- Occurs rapidly, often before the user has time to psychologically adjust. The dismantling of identity can be experienced as annihilation rather than transcendence, particularly in unprepared individuals
- Dark experiential content -- Users consistently report a heavier, darker aesthetic character than psilocybin, LSD, or even DMT. The confrontation with difficult psychological material is a feature, not a bug, but it demands preparation
- Post-experience destabilization -- The intensity of DPT can leave users psychologically fragile for days to weeks. Integration support is not optional
- Psychosis risk -- Absolute contraindication for individuals with personal or family history of schizophrenia, schizoaffective disorder, or bipolar I disorder. The intensity of DPT makes this contraindication even more urgent than for gentler psychedelics
- Traumatic experiences -- More so than most psychedelics, DPT can produce sessions that meet subjective criteria for psychological trauma if the user is unprepared or unsupported
Drug Interactions
- MAOIs -- Potentiation with serious risk of overwhelming intensity and serotonin syndrome. DPT is already orally active, so MAOI addition creates compounded risk
- Lithium -- Absolute contraindication; documented seizure risk with serotonergic psychedelics
- Stimulants -- Increased cardiovascular strain and psychological intensity
- Cannabis -- Unpredictable amplification of an already overwhelming experience; strongly discouraged
- Alcohol -- Impaired judgment and increased nausea; no pharmacological benefit
Addiction Potential
DPT has essentially zero addiction potential. It produces no physical dependence, no withdrawal syndrome, and no compulsive drug-seeking behavior. Rapid tolerance develops within 24-48 hours, making repeated daily use pharmacologically futile, and full cross-tolerance with other serotonergic psychedelics (DMT, psilocybin, LSD, mescaline) prevents substitution patterns. Among all drug classes, classical psychedelics rank at the very bottom for addiction liability, and DPT is no exception. If anything, DPT's intensely confrontational character makes it self-limiting in a way that gentler psychedelics are not -- the experience is so demanding that most users who try it space their sessions months to years apart, and a significant number choose never to repeat it. The concept of someone compulsively using DPT the way a person might compulsively use cocaine or heroin is essentially incoherent; it would be like developing a compulsion for root canals. That said, a very small number of individuals may develop a pattern of repeatedly seeking extreme psychedelic experiences as a form of psychological avoidance or spiritual bypassing, but this is rare and categorically distinct from substance addiction.
Overdose Information
Can You Fatally Overdose on DPT?
Fatal overdose from DPT's pharmacological action alone is extremely unlikely based on the therapeutic index of classical tryptamine psychedelics and the absence of documented deaths attributable to DPT toxicity in the clinical or community literature. The 1970s clinical studies administered the compound without observing life-threatening physiological reactions within the therapeutic dose range.
Recognizing a Crisis
With DPT, the crisis is almost always psychological rather than physical. The compound's capacity for profound ego dissolution and dark experiential content means that psychological emergencies are not rare edge cases -- they are a foreseeable risk at full doses.
Watch for:
- Complete disconnection from reality -- the person does not recognize their environment, their sitter, or themselves
- Extreme agitation or terror that does not respond to verbal reassurance
- Dangerous physical behavior -- attempting to flee, self-harm, or interact with hazardous objects while in a dissociated state
- Catatonia -- complete unresponsiveness, which can occur during peak DPT experiences
- Signs of serotonin syndrome (if MAOIs are involved): muscle rigidity, rapidly rising body temperature, tremor, agitation, rapid heart rate
What to Do
For psychological distress: the sitter's composure is the single most important intervention. Speak slowly, clearly, and calmly. Use simple, concrete statements: "You are in your living room. You took DPT. I am here with you. This will end." Physical contact -- a hand on the arm, a weighted blanket -- can provide grounding, but ask or signal before touching someone in a dissociated state. Benzodiazepines (diazepam 10-20 mg) reliably reduce intensity if the person is conscious and able to swallow.
Do not attempt to restrain the person unless there is immediate danger of serious injury. Restraint during psychedelic crisis almost always escalates distress.
For medical emergencies: call emergency services immediately for seizures, dangerously elevated body temperature, signs of serotonin syndrome, loss of consciousness, or any self-harm. Good Samaritan laws protect callers in many jurisdictions. Treatment is supportive -- IV fluids, cooling for hyperthermia, benzodiazepines for agitation. There is no specific DPT antidote.
After a Difficult Experience
DPT experiences -- especially difficult ones -- require active integration. Talk through what happened with someone you trust within the first few days. Consider working with a therapist experienced in psychedelic integration. Avoid all psychedelic use for an extended period. Monitor for persistent symptoms: anxiety, depersonalization, sleep disturbances, intrusive imagery. These are not uncommon after intense DPT sessions and typically resolve within weeks, but seek professional help if they persist.
Tolerance
| Full | Develops almost immediately after ingestion |
| Half | 3 days |
| Zero | 7 days |
Cross-tolerances
Legal Status
Germany: DPT is controlled under the NpSG (New Psychoactive Substances Act) as of July 18, 2019. Production and import with the aim to place it on the market, administration to another person and trading is punishable. Possession is illegal but not penalized.
Latvia: DPT is a Schedule I controlled substance.
New Zealand: DPT is an analogue of DMT, therefore it is a Class C controlled substance in New Zealand.
Sweden: Following its sale as a designer drug, DPT was made illegal in Sweden on January 26, 2016.
Switzerland: DPT is a controlled substance specifically named under Verzeichnis E.
United Kingdom: DPT is a Class A controlled substance in the United Kingdom as a result of the tryptamine catch-all clause.
United States: DPT is unscheduled in most of the United States. However, some states prohibited DPT, making it illegal to buy, sell, or possess:
Florida: DPT is a Schedule I controlled substance.
Maine: DPT is a Schedule X controlled substance.
Oklahoma: DPT is a Schedule I controlled substance.
Responsible use
Research chemical
Psychedelics
Tryptamines
DMT
DPT (Wikipedia)
DPT (Erowid Vault)
DPT (TiHKAL / Isomer Design)
Soskin, R.A., Grof, S., & Richards, W.A. (1973). Low doses of Dipropyltryptamine in psychotherapy. Archives of General Psychiatry, 28 6, 817-21.
Richards, W. A., Rhead, J. C., DiLeo, F. B., Yensen, R., & Kurland, A. A. (1977). The peak experience variable in DPT-assisted psychotherapy with cancer patients. Journal of Psychedelic Drugs, 9(1), 1-10. http://dx.doi.org/10.1080/02791072.1977.10472020
Grof, S., Soskin, R. A., Richards, W. A., & Kurland, A. A. (1972). DPT as an adjunct in psychotherapy of alcoholics. International Pharmacopsychiatry, 8(1), 104-115. PMID: 4150711
Li, J., Rice, K.C., & France, C.P. (2007). Behavioral effects of dipropyltryptamine in rats: evidence for 5-HT1A and 5-HT2A agonist activity. Behavioural Pharmacology, 18 4, 283-8.
Experience Reports (4)
Tips (10)
Use a milligram scale to weigh DPT if it comes as a powder. Eyeballing doses of potent psychedelics is irresponsible. A quality 0.001g scale costs under $30 and could prevent a seriously overwhelming experience.
Do not combine DPT with lithium (seizure risk), tramadol (seizure/serotonin syndrome risk), or cannabis at higher doses unless very experienced. Cannabis dramatically intensifies and can destabilize a psychedelic experience.
Oral DPT requires much higher doses (200-350mg) and has inconsistent absorption. Insufflation at 30-80mg is the most common ROA and hits within 10-15 minutes. Be aware that insufflation is very painful — many users describe the burn as among the worst of any research chemical.
Have a trip sitter present, ideally someone with psychedelic experience. They should remain calm and reassuring without being intrusive. A good sitter can make the difference between a challenging experience and a genuine crisis.
DPT has limited safety data compared to more established tryptamines. Start well below your target dose to assess sensitivity. Allergy-test with 1-2mg first. The experience can be intensely dysphoric at higher doses, so having a trip-sitter and a benzodiazepine available is strongly recommended.
DPT is often described as a darker, more intense version of DMT. The headspace can feel sinister or confrontational compared to DMT's often euphoric character. Go in with respect and appropriate set/setting — this is not a party drug.
Community Discussions (6)
See Also
Same Class
References (5)
- Psilocybin produces substantial and sustained decreases in depression and anxiety — Griffiths et al. Journal of Psychopharmacology (2016)paper
- Neural correlates of the LSD experience revealed by multimodal neuroimaging — Carhart-Harris et al. PNAS (2016)paper
- PubChem: DPT
PubChem compound page for DPT (CID: 6091)
pubchem - DPT - TripSit Factsheet
TripSit factsheet for DPT
tripsit - DPT - Wikipedia
Wikipedia article on DPT
wikipedia